ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

ABCL AbCellera Biologics Inc

3,67
0,04 (1,10%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
AbCellera Biologics Inc ABCL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,04 1,10% 3,67 06:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,69 3,64 3,80 3,76 3,63
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.4.202418:05BWAbCellera Presents Data on T-Cell Engagers Against Four..
03.4.202422:05BWAbCellera to Report First Quarter 2024 Financial Results on..
19.3.202421:05BWAbCellera to Present at the Bloom Burton Healthcare..
11.3.202414:00BWAbCellera to Collaborate with Biogen to Discover Therapeutic..
05.3.202422:30BWAbCellera Announces Four Presentations on T-Cell Engagers at..
27.2.202420:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202422:49EDGAR2Form 8-K - Current report
23.2.202422:30BWAbCellera Announces Resignation of Board Member
23.2.202402:15BWAbCellera to Present at Upcoming Investor Conferences in..
20.2.202422:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
20.2.202422:27EDGAR2Form 8-K - Current report
20.2.202422:05BWAbCellera Reports Full Year 2023 Business Results
23.1.202422:05BWAbCellera to Report Full Year 2023 Financial Results on..
17.1.202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202322:05BWAbCellera to Present at the 42nd Annual J.P. Morgan..
20.12.202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202323:28EDGAR2Form 8-K - Current report
27.11.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202322:05BWAbCellera to Present at the Piper Sandler 35th Annual..
08.11.202321:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202317:05BWAbCellera Presents New Data on Two T-Cell Engager Programs..
02.11.202321:13EDGAR2Form 8-K - Current report
02.11.202321:05BWAbCellera Reports Q3 2023 Business Results
01.11.202321:05GLOBEPrelude Therapeutics and AbCellera Enter Partnership to..
31.10.202321:05BWAbCellera to Present at the Jefferies London Healthcare..
11.10.202322:05BWAbCellera to Report Third Quarter 2023 Financial Results on..
27.9.202315:00BWAbCellera Announces Two T-Cell Engager Presentations at SITC..
20.9.202323:02BWAbCellera Expands Multi-Target Antibody Discovery..
20.9.202315:00BWAbCellera Expands Multi-Target Antibody Discovery..
14.9.202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202315:00BWAbCellera Announces Collaboration with Incyte to Accelerate..
25.8.202319:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202322:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:15EDGAR2Form 8-K - Current report
03.8.202322:05BWAbCellera Reports Q2 2023 Business Results
24.7.202322:05BWAbCellera Announces that the U.S. Patent Trial and Appeal..
06.7.202322:05BWAbCellera to Report Second Quarter 2023 Financial Results on..
29.5.202322:05BWAbCellera to Present at the Goldman Sachs 44th Annual Global..
24.5.202319:10BWAbCellera Partners with the Governments of Canada and..
04.5.202322:05BWAbCellera Reports Q1 2023 Business Results

Kürzlich von Ihnen besucht

Delayed Upgrade Clock